The characteristics and impact of pruritus in in adult dermatologic patients: a prospective, cross-sectional study

by admin | Jun 1, 2021

Background: Pruritus often accompanies chronic skin diseases, exerting considerable burden on manyareas of patient functioning; this burden and the features of pruritus remain insufficiently characterized.Objective:To investigate characteristics, including...

Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study

by admin | Jun 1, 2021

Background: An objective of the phase 3 HELP Study was to investigate the effect of lanadelumab on health-related quality of life (HRQoL) in patients with hereditary angioedema (HAE). Methods: Patients with HAE-1/2 received either lanadelumab 150 mg every 4 weeks...

Treatment of severe heat urticaria with omalizumab – report of a case and review of the literature

by admin | Nov 13, 2020

We report the case of a 51-year-old female patient with severe chronic heat urticaria (HU), a rare form of chronic inducible urticaria (CIndU). Skin symptoms started at the age of 49 years, when our patient first observed that direct skin contact with hot water while...

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results

by admin | Nov 13, 2020

Background: A Worldwide Antihistamine-Refractory Chronic Urticaria (CU) patient Evaluation (AWARE) is a non-interventional, multicenter study including patients from Europe, Central and Latin America, Asia-Pacific, and the Middle East. AWARE describes real-world...

Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study

by admin | Nov 12, 2020

Background: Real-world evidence describing the benefits of recommended therapies and their impact on the quality of life (QoL) of chronic urticaria (CU) patients is limited. Objective: To investigate disease burden, current treatment schedule, and the use of clinical...